From silico to benchtop: cosmosiin as a PD-1/PDL-1 immune checkpoint inhibitor revealed through DFT, network pharmacology analysis, and molecular docking integrated experimental verificationReem I. Alsantali, Saleh A. Ahmed|RSC Advances|2025Cited by 6